314 related articles for article (PubMed ID: 17057003)
1. Prognostic accuracy of 12 liver staging systems in patients with unresectable hepatocellular carcinoma treated with transarterial chemoembolization.
Georgiades CS; Liapi E; Frangakis C; Park JU; Kim HW; Hong K; Geschwind JF
J Vasc Interv Radiol; 2006 Oct; 17(10):1619-24. PubMed ID: 17057003
[TBL] [Abstract][Full Text] [Related]
2. Comparison of current staging systems for advanced hepatocellular carcinoma not amendable to locoregional therapy as inclusion criteria for clinical trials.
Li X; Dong M; Lin Q; Chen ZH; Ma XK; Xing YF; Wan XB; Wen JY; Wei L; Chen J; Wu XY
Asia Pac J Clin Oncol; 2013 Mar; 9(1):86-92. PubMed ID: 23279888
[TBL] [Abstract][Full Text] [Related]
3. Prognostic nomogram for patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization.
Xu L; Peng ZW; Chen MS; Shi M; Zhang YJ; Guo RP; Lin XJ; Lau WY
J Hepatol; 2015 Jul; 63(1):122-30. PubMed ID: 25725438
[TBL] [Abstract][Full Text] [Related]
4. Re: Prognostic accuracy of 12 liver staging systems in patients with unresectable hepatocellular carcinoma treated with transarterial chemoembolization.
Clark TW
J Vasc Interv Radiol; 2007 Mar; 18(3):456; author reply 456-7. PubMed ID: 17377198
[No Abstract] [Full Text] [Related]
5. Re: Prognostic accuracy of 12 liver staging systems in patients with unresectable hepatocellular carcinoma treated with transarterial chemoembolization.
Cho YK
J Vasc Interv Radiol; 2007 Mar; 18(3):455; author reply 455-6. PubMed ID: 17377196
[No Abstract] [Full Text] [Related]
6. Evaluation of survival of patients with hepatocellular carcinoma: A comparative analysis of prognostic systems.
Tannus RK; Almeida-Carvalho SR; Loureiro-Matos CA; Miziara-Gonzalez A; Salzedas-Netto AA; Szejnfeld D; D'Ippolito G; Pereira-Lanzoni V; Souza-Silva I
PLoS One; 2018; 13(4):e0194922. PubMed ID: 29617435
[TBL] [Abstract][Full Text] [Related]
7. Prognostic accuracy of staging systems in patients with primary liver cancer undergoing transarterial chemoembolization.
Zhuge Y; Zhang F; Qiu Y; Li Z; Zhang J
Hepatogastroenterology; 2013 May; 60(123):481-8. PubMed ID: 23635440
[TBL] [Abstract][Full Text] [Related]
8. Inflammation scores predict survival for hepatitis B virus-related hepatocellular carcinoma patients after transarterial chemoembolization.
Zhou DS; Xu L; Luo YL; He FY; Huang JT; Zhang YJ; Chen MS
World J Gastroenterol; 2015 May; 21(18):5582-90. PubMed ID: 25987783
[TBL] [Abstract][Full Text] [Related]
9. Value of the model for end-stage liver disease for predicting survival in hepatocellular carcinoma patients treated with transarterial chemoembolization.
Kim JH; Kim JH; Choi JH; Kim CH; Jung YK; Yim HJ; Yeon JE; Park JJ; Kim JS; Bak YT; Byun KS
Scand J Gastroenterol; 2009; 44(3):346-57. PubMed ID: 18991165
[TBL] [Abstract][Full Text] [Related]
10. Survival, efficacy, and safety of small versus large doxorubicin drug-eluting beads TACE chemoembolization in patients with unresectable HCC.
Prajapati HJ; Xing M; Spivey JR; Hanish SI; El-Rayes BF; Kauh JS; Chen Z; Kim HS
AJR Am J Roentgenol; 2014 Dec; 203(6):W706-14. PubMed ID: 25415737
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of doxorubicin drug-eluting bead transarterial chemoembolization in patients with advanced hepatocellular carcinoma.
Prajapati HJ; Dhanasekaran R; El-Rayes BF; Kauh JS; Maithel SK; Chen Z; Kim HS
J Vasc Interv Radiol; 2013 Mar; 24(3):307-15. PubMed ID: 23375519
[TBL] [Abstract][Full Text] [Related]
12. Transarterial chemoembolization for inoperable, early stage hepatocellular carcinoma in patients with Child-Pugh grade A and B: results of a comparative study in 96 Chinese patients.
Yuen MF; Chan AO; Wong BC; Hui CK; Ooi GC; Tso WK; Yuan HJ; Wong DK; Lai CL
Am J Gastroenterol; 2003 May; 98(5):1181-5. PubMed ID: 12809846
[TBL] [Abstract][Full Text] [Related]
13. Advanced hepatocellular carcinoma: which staging systems best predict prognosis?
Huitzil-Melendez FD; Capanu M; O'Reilly EM; Duffy A; Gansukh B; Saltz LL; Abou-Alfa GK
J Clin Oncol; 2010 Jun; 28(17):2889-95. PubMed ID: 20458042
[TBL] [Abstract][Full Text] [Related]
14. A prognostic score for patients with intermediate-stage hepatocellular carcinoma treated with transarterial chemoembolization.
Ogasawara S; Chiba T; Ooka Y; Kanogawa N; Motoyama T; Suzuki E; Tawada A; Azemoto R; Shinozaki M; Yoshikawa M; Yokosuka O
PLoS One; 2015; 10(4):e0125244. PubMed ID: 25919025
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors for survival in patients with unresectable hepatocellular carcinoma undergoing chemoembolization with doxorubicin drug-eluting beads: a preliminary study.
Dhanasekaran R; Kooby DA; Staley CA; Kauh JS; Khanna V; Kim HS
HPB (Oxford); 2010 Apr; 12(3):174-80. PubMed ID: 20590884
[TBL] [Abstract][Full Text] [Related]
16. Predicting Survival Using Pretreatment CT for Patients With Hepatocellular Carcinoma Treated With Transarterial Chemoembolization: Comparison of Models Using Radiomics.
Kim J; Choi SJ; Lee SH; Lee HY; Park H
AJR Am J Roentgenol; 2018 Nov; 211(5):1026-1034. PubMed ID: 30240304
[TBL] [Abstract][Full Text] [Related]
17. Comparison of seven prognostic staging systems in patients who undergo hepatectomy for hepatocellular carcinoma.
Kondo K; Chijiiwa K; Nagano M; Hiyoshi M; Kai M; Maehara N; Ohuchida J; Nakao H; Ohkuwa Y
Hepatogastroenterology; 2007; 54(77):1534-8. PubMed ID: 17708292
[TBL] [Abstract][Full Text] [Related]
18. Impact of the Interval between Transarterial Chemoembolization Sessions on Survival in Patients with Unresectable Hepatocellular Carcinoma.
Kim HD; An J; Kim JH; Gwon DI; Shin JH; Ko GY; Yoon HK; Sung KB; Kim KM; Lee HC
J Vasc Interv Radiol; 2016 Apr; 27(4):504-13. PubMed ID: 26896049
[TBL] [Abstract][Full Text] [Related]
19. A Modified Model for Assessment for Retreatment with Transarterial Chemoembolization in Chinese Hepatocellular Carcinoma Patients.
Chen L; Ni CF; Chen SX; Cao JM; Zhu HD; Guo JH; Zhu GY; Zhong BY; Ding W; He SC; Deng G; Teng GJ
J Vasc Interv Radiol; 2016 Sep; 27(9):1288-1297. PubMed ID: 27013402
[TBL] [Abstract][Full Text] [Related]
20. Comparison of survival of patients with BCLC stage A hepatocellular carcinoma after hepatic resection or transarterial chemoembolization: a propensity score-based analysis.
Guo Z; Zhong JH; Jiang JH; Zhang J; Xiang BD; Li LQ
Ann Surg Oncol; 2014 Sep; 21(9):3069-76. PubMed ID: 24728740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
